about
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, inject...
Read More
58.74
-0.43
(-0.73%)
11.9M
XNYS Volume
XNYS 02 Oct, 2025 5:30 PM (EDT)
Medium Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks.
View Similar
Embed DVM
Novo Nordisk ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..